» Articles » PMID: 32867236

Eighteen New Aeruginosamide Variants Produced by the Baltic Cyanobacterium CCNP1324

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2020 Sep 2
PMID 32867236
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cyanobactins are a large family of ribosomally synthesized and post-translationally modified cyanopeptides (RiPPs). Thus far, over a hundred cyanobactins have been detected in different free-living and symbiotic cyanobacteria. The majority of these peptides have a cyclic structure. The occurrence of linear cyanobactins, aeruginosamides and virenamide, has been reported sporadically and in few cyanobacterial taxa. In the current work, the production of cyanobactins by sp. CCNP1324, isolated from the brackish water Baltic Sea, has been studied for the first time. In the strain, eighteen new aeruginosamide (AEG) variants have been detected. These compounds are characterized by the presence of prenyl and thiazole groups. A common element of AEGs produced by sp. CCNP1324 is the sequence of the three C-terminal residues containing proline, pyrrolidine and methyl ester of thiazolidyne-4-carboxylic acid (Pro-Pyr-TzlCOOMe) or thiazolidyne-4-carboxylic acid (Pro-Pyr-TzlCOOH). The aeruginosamides with methylhomotyrosine (MeHTyr) and with the unidentified -terminal amino acids showed strong cytotoxic activity against human breast cancer cells (T47D).

Citing Articles

Recent Advances in Discovery, Bioengineering, and Bioactivity-Evaluation of Ribosomally Synthesized and Post-translationally Modified Peptides.

Zhong G, Wang Z, Yan F, Zhang Y, Huo L ACS Bio Med Chem Au. 2023; 3(1):1-31.

PMID: 37101606 PMC: 10125368. DOI: 10.1021/acsbiomedchemau.2c00062.


Beyond Soil-Dwelling Actinobacteria: Fantastic Antibiotics and Where to Find Them.

Santos-Aberturas J, Vior N Antibiotics (Basel). 2022; 11(2).

PMID: 35203798 PMC: 8868522. DOI: 10.3390/antibiotics11020195.


Biological Activity and Stability of Aeruginosamides from Cyanobacteria.

Ceglowska M, Kwiecien P, Szubert K, Brzuzan P, Florczyk M, Edwards C Mar Drugs. 2022; 20(2).

PMID: 35200623 PMC: 8878463. DOI: 10.3390/md20020093.


Characterization and Diversity of Microcystins Produced by Cyanobacteria from the Curonian Lagoon (SE Baltic Sea).

Overlinge D, Torunska-Sitarz A, Katarzyte M, Pilkaityte R, Gyraite G, Mazur-Marzec H Toxins (Basel). 2021; 13(12).

PMID: 34941676 PMC: 8703916. DOI: 10.3390/toxins13120838.


Cyanobacterial Toxins and Peptides in Lake Vegoritis, Greece.

Zervou S, Moschandreou K, Paraskevopoulou A, Christophoridis C, Grigoriadou E, Kaloudis T Toxins (Basel). 2021; 13(6).

PMID: 34205997 PMC: 8230288. DOI: 10.3390/toxins13060394.

References
1.
Wang Y, Li Y, Liu X, Lu X, Cao X, Jiao B . Marine Antibody-Drug Conjugates: Design Strategies and Research Progress. Mar Drugs. 2017; 15(1). PMC: 5295238. DOI: 10.3390/md15010018. View

2.
McIntosh J, Lin Z, Tianero M, Schmidt E . Aestuaramides, a natural library of cyanobactin cyclic peptides resulting from isoprene-derived Claisen rearrangements. ACS Chem Biol. 2013; 8(5):877-83. PMC: 3657307. DOI: 10.1021/cb300614c. View

3.
Donia M, Ravel J, Schmidt E . A global assembly line for cyanobactins. Nat Chem Biol. 2008; 4(6):341-3. PMC: 2862271. DOI: 10.1038/nchembio.84. View

4.
Luesch H, Moore R, Paul V, Mooberry S, Corbett T . Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J Nat Prod. 2001; 64(7):907-10. DOI: 10.1021/np010049y. View

5.
Portmann C, Blom J, Kaiser M, Brun R, Juttner F, Gademann K . Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation. J Nat Prod. 2008; 71(11):1891-6. DOI: 10.1021/np800409z. View